相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA)
Paul R. Rhomberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia - a double blind prospective multicentre study
D. V. Schmitt et al.
INFECTION (2006)
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics
Masahito Horiuchi et al.
TOXICOLOGY (2006)
Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa -: The high potency of a new carbapenem doripenem
Shihomi Sakyo et al.
JOURNAL OF ANTIBIOTICS (2006)
Nosocomial pneumonia: State of the science
SA Flanders et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2006)
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia
Maniari Joshi et al.
RESPIRATORY MEDICINE (2006)
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)
TR Fritsche et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria
E Giantsou et al.
INTENSIVE CARE MEDICINE (2005)
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms
RN Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: A prospective, matched analysis
VD Rosenthal et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Levofloxacin for treatment of ventilator-associated pneumonia: A subgroup analysis from a randomized trial
AF Shorr et al.
CLINICAL INFECTIOUS DISEASES (2005)
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the united states today surveillance studies
JA Karlowsky et al.
CLINICAL INFECTIOUS DISEASES (2005)
Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy
SC Lee et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Doripenem versus Pseudomonas aeruginosa in vitro:: Activity against characterized isolates, mutants, and transconjugants and resistance selection potential
S Mushtaq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Activities of doripenem (S-4661) against drug-resistant clinical pathogens
RN Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome
CM Luna et al.
CRITICAL CARE MEDICINE (2003)
Nosocomial pneumonia: A cost-of-illness analysis
ES Dietrich et al.
INFECTION (2002)
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients:: a prospective randomized multicenter trial
F Alvarez-Lerma et al.
INTENSIVE CARE MEDICINE (2001)
Antibiotic resistance in the intensive care unit
MH Kollef et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
